Sitagliptin (50mg), Metformin SR 1000 & ST-GLIPTIN M50/1000 :Benefits, Dosage, Side Effects.

ST-GLIPTIN M50/1000

Sitagliptin (50mg), Metformin SR 1000

ST-GLIPTIN M50/1000 is a combination medication comprising Sitagliptin 50mg and Metformin SR 1000mg. This article aims to provide a comprehensive overview of the composition, mechanism of action, therapeutic uses, dosage guidelines, potential side effects, price, and more about Sitagliptin (50mg) and Metformin SR 1000 and their role in managing type 2 diabetes mellitus.

Understanding Sitagliptin (50mg) and Metformin SR 1000:

1. Sitagliptin (50mg): A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases insulin secretion and reduces glucagon levels, aiding in glycemic control.
2. Metformin SR 1000: A first-line oral antidiabetic medication that improves insulin sensitivity, decreases hepatic glucose production, and enhances glucose utilization in peripheral tissues.

Key Benefits and Uses:

1. Glycemic Control: ST-GLIPTIN M50/1000 is prescribed to lower blood sugar levels and improve overall glycemic control in patients with type 2 diabetes.
2. Postprandial Glucose Management: Sitagliptin targets postprandial hyperglycemia, while Metformin SR regulates fasting glucose levels, providing comprehensive glucose control.
3. Insulin Sensitization: Metformin SR component enhances insulin sensitivity, aiding in glucose uptake and utilization by cells.
4. Cardiovascular Benefits: Studies suggest potential cardiovascular benefits associated with Metformin use, making it beneficial for diabetic patients with cardiovascular risk factors.

Dosage and Administration:

The recommended dosage of ST-GLIPTIN M50/1000 (Sitagliptin 50mg, Metformin SR 1000) is determined by healthcare providers based on individual patient needs, diabetes status, and response to treatment. It is usually taken orally with meals to minimize gastrointestinal side effects.

Potential Side Effects and Precautions:

Common side effects of ST-GLIPTIN M50/1000 may include gastrointestinal disturbances (nausea, diarrhea), mild hypoglycemia, and weight changes. Patients with specific medical conditions or on other medications should consult healthcare professionals before starting this combination therapy.

Price and Availability:

ST-GLIPTIN M50/1000 (Sitagliptin 50mg, Metformin SR 1000) is available in pharmacies and healthcare facilities, with prices varying based on brand and formulation. Generic alternatives may offer cost-effective options for patients. It is typically prescribed as part of a comprehensive diabetes management plan.

Conclusion:

In conclusion, ST-GLIPTIN M50/1000 with Sitagliptin (50mg) and Metformin SR 1000 presents a synergistic approach to managing type 2 diabetes mellitus. Its dual action on glycemic control, insulin sensitivity, and potential cardiovascular benefits make it a valuable therapeutic option for individuals striving for optimal diabetes care. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW